Who is the CEO of Gelteq Limited Ordinary Shares?

The CEO of Gelteq Limited Ordinary Shares is Nathan Jacob Givoni.

What industry does Gelteq Limited Ordinary Shares belong to?

Gelteq Limited Ordinary Shares operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

Where is Gelteq Limited Ordinary Shares headquartered?

Gelteq Limited Ordinary Shares is headquartered at 641 Glen Huntly Road, Caulfield, VIC, 3162, AU.

How many employees does Gelteq Limited Ordinary Shares have?

Gelteq Limited Ordinary Shares has approximately 7 full-time employees.

Gelteq Limited Ordinary Shares

GELS•NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

$1.88

$0.03(1.62%)

Gelteq Limited Ordinary Shares (GELS) Company Profile & Overview

Explore Gelteq Limited Ordinary Shares’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Gelteq Limited Ordinary Shares (GELS) Company Profile & Overview

Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

CEONathan Jacob Givoni

Contact Information

https://www.gelteq.com

61 3 9087 3990

641 Glen Huntly Road, Caulfield, VIC, 3162

Company Facts

7 Employees

CountryAU

Actively Trading

Frequently Asked Questions

;